Implementation of HEA beadchip system at medical centers: Providing extended matched units and eliminating complex workups for patients

BeadChip Molecular Immunohematology: Toward Routine Donor and Patient Antigen Profiling by DNA Analysis

Volumn , Issue , 2011, Pages 57-71

  Klapper, Ellen ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Alloimmunization; Autoantibodies; Blood group antigens; Blood groups; DNA array; DNA testing

Indexed keywords

EID: 84900579694     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-7512-6_5     Document Type: Chapter

References (15)

1. Petz LD (2003) "Least incompatible" units for transfusion in autoimmune hemolytic anemia: should we eliminate this meaningless term? A commentary for clinicians and transfusion medicine professionals [editorial]. Transfusion 43:1503-1507
2. Rios M, Hue-Roye K, Storry JR et al. (2000) Cell typing the sensitized transfusion-dependent patient. Ann Clin Lab Sci 4:379-386
3. Lee E, Burgess G, Halverson GR et al. (2004) Applications of murine and humanized chima-eric monoclonal antibodies for red cell phenotyping. Br J Haematol 126:277-281
4. Shirey RS, Boyd JS, Parwani AV et al. (2002) Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management. Transfusion 42:1435-1441
5. Vichinsky EP, Luban NL, Wright E et al. (2002) Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 41:1086-1092
6. Castro O, Sandler SG, Houston-Yu P, Rana S (2002) Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 42:684-690
7. Porter J (2009) Blood transfusion: quality and safety issues in thalassemia, basic requirements and new trends. Hemoglobin 33(Suppl 1):S28-S36
8. Denomme GA, Wagner FF, Fernandes BJ et al. (2005) Partial D, weak D types, and novel RHD alleles among 33, 864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion 45:1554-1560
9. Tournamille C, Meunier-Costes N, Costes B et al. (2010) Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion 50:13-19
10. Osby M, Shulman IA (2005) Phenotype matching of donor red blood cell units for nonalloim-munized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 129:190-193
11. Abumuhor IA, Klapper EB, Smith LE (2009) The value of maintaining special screened RBC inventory by molecular testing in a tertiary care hospital. Transfusion 49(Suppl):242A (A22-030H)
12. Hashmi G (2007) Red blood cell antigen phenotype by DNA analysis. Transfusion 47(1 Suppl):60S-63S
13. Castilho L, Credidio DC, Ribeiro K et al. (2009) Anti-Fy3 in sickle cell disease patients genotyped as FY*B-33/FY*B-33. Transfusion 49(Suppl):35A (S83-030K)
14. Klapper E, Zhang Y, Figueroa P, et al. (2010) Toward extended phenotype matching: a new operational paradigm for the transfusion service, Transfusion 50(3):536-546
15. Rosse WF, Gallagher D, Kinney TR et al. (1990) Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 76:1431-1437